Stay updated on PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:52:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a nearby study center.
    Difference
    0.3%
    Check dated 2025-04-23T22:28:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include the term 'Diabetes Mellitus' and a new EudraCT number, while significant details about the study's purpose, inclusion and exclusion criteria, and study design have been removed.
    Difference
    9%
    Check dated 2025-04-16T14:46:16.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:58:40.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:34:01.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.
    Difference
    0.9%
    Check dated 2025-02-24T21:05:16.000Z thumbnail image

Stay in the know with updates to PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.